Hercules, CA – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced that it has received Premarket Application approval from the U.S. Food and Drug Administration for Bio-Rad’s fourth-generation HIV assay, the GS HIV Combo Ag/Ab EIA (enzyme immunoassay). The GS HIV […]
Today, at the 2011 American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo, Phadia, the global leader in allergy and autoimmune disease-related diagnostics, demonstrates how ImmunoCAP Molecular Allergy can help improve the diagnosis and management of food allergy. With heightened awareness of the impact, prevalence, cost, and severity of food allergies, ImmunoCAP […]
ROCKVILLE, Maryland and SEOUL, Korea – Seegene today announced that Anyplex™ MTB/NTM/DR-TB Real-time Test, a total solution for diagnosing (MTB), will be introduced at the 2011 Annual Meeting and Clinical Lab Expo of the American Association for Clinical Chemistry in Atlanta, GA, July 26-28, 2011. Every year 9.4 million people are newly infected with MTB, […]
Atlanta – Waters Corporation (WAT:NYSE) today unveiled new technology solutions for increasing clinical laboratory efficiencies including the first CE Marked LC/MS/MS integrated solution for the quantification of everolimus (Certican®). Being displayed in Waters booth #3136 are these exciting new products. • MassTrak™ Online Solid Phase Extraction Analyzer providing automated sample clean-up, concentration, and extraction complemented […]
ATLANTA – Waters Corporation (NYSE: WAT) today announced that its MassTrak™ Immunosuppressants XE Kit is now CE-marked in accordance with the IVD Directive 98/79/EC, for the quantitative measurement of the immunosuppressive drugs tacrolimus (FK506;Prograf®) in liver and kidney transplant patients and everolimus (Certican®) in adult kidney and cardiac transplant patients from human whole blood samples […]
WALTHAM, Mass. – Thermo Fisher Scientific (NYSE:TMO), the world leader in serving science, today announced it has signed a long-term license agreement with Alere Inc. to integrate its novel Thermo Scientific B.R.A.H.M.S. biomarker assays on Alere’s leading point-of-care Triage® platform. Alere, formerly Inverness Medical Innovations, is a global leader in rapid point-of-care diagnostics. Increased availability […]
Boulder, CO – MBio Diagnostics, Inc. today announced it has received an award from the US National Institutes of Health to detect disease-causing respiratory pathogens in humans. The five-year, $5.2 million award from NIH’s “Partnerships for Biodefense” program will address two major public health needs: a rapid, inexpensive influenza diagnostic with performance superior to commonly […]
ROCKVILLE, Maryland and SEOUL, Korea – Seegene today announced that it will unveil TOCE™, a new platform technology for real-time PCR, at the 2011 Clinical Lab Expo of the American Association for Clinical Chemistry (AACC), booth #1653. TOCE™ is a novel technology for melting curve analysis.The method is readily used for organism identification and the […]
NEWARK, DE – SDIX (NASDAQ: SDIX), a leading provider of In Vitro Diagnostic (IVD) reagents, today announced its plan to introduce a new polyclonal antisera to its product line for the IVD market. The product, Apo B, will be available as antisera and in fractionated forms. Antibodies to Apo B will be launched on July […]
CAMBRIDGE, Mass. and SALZBURG, Austria – Quanterix Corporation, enabling a new generation of diagnostic tests based on the revolutionary Single Molecule Array (SiMoA™) technology, and Sony DADC Austria AG, today announced that they have entered into a collaboration for the development and manufacture of “smart consumables” for use in the life science and in vitro […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
